Merrimack Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
Based in Cambridge, Massachusetts, Merrimack operates in the biotechnology research and biopharmaceutical space with a focus on cancer therapies. It aims to transform cancer care by designing targeted treatments informed by cancer biology and biomarkers. The company's portfolio includes four clinical studies across distinct indications and six preclinical candidates, all organized around a three-part strategy to understand the biological problems, craft precise solutions, and develop them for biomarker-selected patients. Within the oncology-focused segment of the biopharmaceutical industry, Merrimack emphasizes approaches that pair biological insights with biomarker-driven patient selection to optimize outcomes. Headquartered in Cambridge, the company is a mid-sized enterprise by scale. Its focus on biomarker-guided development reflects a disciplined effort to advance targeted therapies from research into clinical development while prioritizing patient-specific considerations.